Skip to content

OPTIMIS

Inactive KBO/BCE: BE 0895.194.390 subsidiary of Newpharma Group
OPTIMIS
Follow Report

Overview

Lifetime

11 annual accounts with figures on one time axis
peak €82,090 (2014)
-not published
lowest -€7,263 (2008)
-€4,701▼ €3,774
peak €506,622 (2014)
€307,437▼ 1.5%
€992▼ 98.9%
Owners
100%NEWPHARMA GROUP
Documentsfilings and deeds
25-07-20196 days before the deadline
2018financial year
Loss of €4,701Debts from €91,776 to €992Cash from €97,184 to €2,359

Key points

from the 2018 annual accounts, the last ones filed

Losses

-€5,747 in three years
-1192016-9272017-4,7012018

Every financial year from 2016 to 2018 closed with a loss. 2018 was the heaviest.

Filings

11 annual accounts since 2008
AprilJune31 JulyOctober20102015

Three of the last ten came late. The 2014 accounts came latest: 54 days after the end of the period.

No score

Board and ownership

  • Newpharma Group consolidatesscore 86equity €86.3m (2026) · annual accounts 2018
Board & ownership

Recent changes

Merger: absorbed by NEWPHARMA GROUP Cancellation of 186 shares · NEWPHARMA GROUP holds all the shares · General meeting of 28-05-2019 · Gazette deed
Merger proposal: to be absorbed by NEWPHARMA GROUP Permanent representatives: Dieter Struye, Jérôme Gobbesso, Dries Colpaert, Olivier Witmeur and Thomas De Kempeneer · NEWPHARMA GROUP holds all the shares · Board meeting of 02-04-2019 · Gazette deed
Incorporation 7 publications in the Belgian Official Gazette, the last on 27-06-2019 · Gazette deed
All 19 events

Official details

Source: KBO
Status
Inactivedeed of incorporation of 04-02-2008 · last publication under the heading Restructuring on 27-06-2019
Activity
“La participation directe ou indirecte dans toutes sociétés” (deed in French)From the articles, 8 activitiesNo NACE code in the KBO yet
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2018

€4,701
€307,437
€308,429
Filing
Filed on 25-07-2019
Financials

Insights on OPTIMIS

Inactive. The last annual accounts are for financial year 2018.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2018

full format, filed on 25-07-2019, 6 days before the deadline
€307,437
▼ 1.5%
-€4,464
▼ €2,566
-€4,701
▼ €3,774
€1,367
▼ 76.0%
99.7%
▲ 22.4 percentage points
2.38
▲ 1.32

Turnover: not included in this filing.

Balance sheet

balance sheet total €308,429 on 31-12-2018
What the company ownsHow it is paid for

in euro

in euro

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20182017201620152014201320122011201020092008
Balance sheet: assets
20/58 308,429403,914399,675619,127660,157145,67657,34156,63032,36119,32715,392
21/28 306,070306,449306,499306,499316,57918,4413,4002,6202,5503,9962,942
22/27 ----10,08015,442402--1,4462,892
24 ----10,08015,442402--1,4462,892
28 306,070306,449306,499306,499306,4992,9992,9982,6202,5502,55050
280/1 306,070----------
280 306,070----------
29/58 2,35997,46593,176312,628343,578127,23553,94154,01029,81115,33112,450
40/41 -282355294,535320,354123,65650,92143,15826,42812,1006,090
40 -28233317,37450,668121,10044,37538,38125,43112,1006,050
41 --23277,161269,6872,5566,5464,776997-40
54/58 2,35997,18492,72917,40419,811632,40110,5442,7113,2316,036
490/1 --916893,4133,516618309672-324
Balance sheet: equity and liabilities
10/49 308,429403,914399,675619,127660,157145,67657,34156,63032,36119,32715,392
10/15 307,437312,138306,864306,984506,62238,70010,36417,2238,6735,4805,137
10/11 18,60018,60012,40012,40012,40012,40012,40012,40012,40012,40012,400
100 18,60018,60018,60018,60018,60018,60018,60018,60018,60018,60018,600
101 --6,2006,2006,2006,2006,2006,2006,2006,2006,200
13 1,8601,8601,8601,8601,8601,8601,8601,8601717-
130 1,8601,8601,8601,8601,8601,8601,8601,8601717-
14 286,977291,678292,604292,724492,36224,440-3,8962,963-3,744-6,937-7,263
17/49 99291,77692,810312,143153,536106,97646,97739,40723,68813,84710,255
42/48 99291,77692,810301,722143,86998,15438,52231,23915,94213,84710,255
44 992173642,63520,38110,3052,8581,4804,0767995,196
440/4 992173642,63520,38110,3052,8581,4804,0767995,196
46 ------11,000----
45 --63014,56546,38216,00985619,76011,8653,806361
450/3 --63014,56546,38216,00985619,76011,8653,806361
47/48 -91,60392,116284,52277,10771,84023,80810,000-9,2424,698
492/3 ---10,4219,6668,8228,4558,1687,746--
Income statement
76A --2006,820-------
9900 --1,551-1,12614,51782,09079,958-2,86834,72713,2746,675-1,701
60/66A 4,464----------
61 4,053----------
630 ---4378,8017,820201-1,4461,4462,641
640/8 4113488682,8341,1352,2811,416751541348540
9901 -4,464-1,898-1,99411,24672,15469,857-4,48633,97611,2864,882-4,882
75/76B 51,0983,7069,473426,500--1675278-
75 51,0983,7069,473426,500--1675278-
752/9 5----------
65/66B 2421261884133605121,5021,8722,2402,6162,021
65 2421261884133605121,5021,8722,2402,6162,021
652/9 242----------
9903 -4,701-9271,52427,127498,29469,345-5,98832,2709,0992,343-6,903
67/77 --1,6449,76430,37216,00987113,7205,9062,000361
9904 -4,701-927-11917,362467,92253,336-6,85918,5503,193343-7,263
9905 -4,701-927-11917,362467,92253,336-6,85918,5503,193343-7,263
Appropriation of the result
9906 286,977291,678292,604509,724492,36249,440-3,89614,806-3,744-6,920-7,263
691/2 -------1,843-17-
6920 -------1,843-17-
694/7 ---217,000-25,000-10,000---
694 ---217,000---10,000---
695 -----25,000-----
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

Source: Annual accounts 2018 (PDF), filed on 25-07-2019.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2018 full format 25-07-2019 2019-37200505 PDF
31-12-2017 full format 31-07-2018 2018-39300089 PDF
31-12-2016 micro format 13-07-2017 2017-30300288 PDF
31-12-2015 abbreviated format 09-08-2016 2016-41500375 PDF
31-12-2014 abbreviated format 23-09-2015 2015-59300408 PDF
31-12-2013 abbreviated format 29-08-2014 2014-56100413 PDF
31-12-2012 abbreviated format 05-07-2013 2013-26500008 PDF
31-12-2011 abbreviated format 05-07-2012 2012-25600170 PDF
31-12-2010 abbreviated format 17-06-2011 2011-17400040 PDF
31-12-2009 abbreviated format 08-06-2010 2010-15300208 PDF
31-12-2008 abbreviated format 30-07-2009 2009-49300323 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20182017201620152014201320122011201020092008
---11,68480,95577,677-4,285-12,7326,327-2,241
---17,799476,72261,156-6,658-4,6391,789-4,623
---2,060309,43922,8619817002,5005,909
-94,8244,45475,325-2,40719,749-2,338-8,1437,832-519-2,806-
1,3675,68936510,906199,70929,08115,41822,77113,8691,4842,195
99.7%77.3%76.8%49.6%76.7%26.6%18.1%30.4%26.8%28.4%33.4%
2.381.061.001.042.391.301.401.731.871.111.21
0.000.290.301.020.302.764.532.292.732.532.00
-1.5%-0.3%0.0%5.7%92.4%137.8%-66.2%107.7%36.8%6.3%-141.4%
-1.5%-0.2%0.0%2.8%70.9%36.6%-12.0%32.8%9.9%1.8%-47.2%
89 days----------

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Insights on OPTIMIS

The operating result for 2018 is a loss of €4,464, larger than the loss of €1,898 in 2017. It is the lowest result since 2012.

Debt's share of the balance-sheet total falls from 22.7% to 0.3%. Equity and debt are lower.

Board & ownership

Control

Consolidating parent
Newpharma Group
Equity €86.3m
Profit €138,686 in 2026 (loss €42,260 in 2025)
Checked score 86
Source: parent in own accounts 2018
consolidates
This company
OPTIMIS
Equity €307,437
Loss €4,701 in 2018

Capital

Capital
€18,600
Source
2018 annual accounts

Owners through the years

as the annual accounts name them
NEWPHARMA GROUP
consolidates100%
100%
Owners as a list

Source: parent in its own accounts, lists of holdings in the owners' accounts

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 27-06-2019 ↗

Office holders in the KBO →

Network & group

Holdings

own 2018 accounts, the bar shows equity in euros
This companyOPTIMIS1 holding, 1 country 2018 accounts

Belgium 1 Equity Result

  • BE SKYCO50%no longer active €1.7m result -€13,048

Source: list of holdings in its own 2018 accounts. Every holding stands with its own latest accounts.

Parent

Newpharma Group
0684.465.652 · equity €86.3m · profit €138,686 (2026)
Checked score 86

Holdings through the years

2017 to 2018
Holdings through the years
Name20172018
SKYCO 50%

Source: list of holdings in its own accounts

Acquisitions and mergers

1 transaction
Taken over by:NEWPHARMA GROUP
BE 0684.465.652proposal · Gazette deed of 18-04-2019

Connections & network

Depth

The network starts from the shareholders of OPTIMIS. Every company they also own or run is a node.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Timeline

19 events since 2008
2019
Annual accounts 2018 filed PDFfull format · 6 days before the deadline
Merger: absorbed by NEWPHARMA GROUPCancellation of 186 shares · NEWPHARMA GROUP holds all the shares · General meeting of 28-05-20194 points ▸
  • General meeting, 28-05-2019
  • Accounting effect, 01-01-2019
  • NEWPHARMA GROUP holds all the shares
  • Net-asset statement, 31-12-2018
  • The deed holds 15 more points.

Open the deed in the Belgian Official Gazette

Merger proposal: to be absorbed by NEWPHARMA GROUPPermanent representatives: Dieter Struye, Jérôme Gobbesso, Dries Colpaert, Olivier Witmeur and Thomas De Kempeneer · NEWPHARMA GROUP holds all the shares · Board meeting of 02-04-201916 points ▸
  • Board meeting, 02-04-2019
  • Board composition, ETABLISSEMENTEN FRANZ COLRUYT (director)
  • Board composition, JGO (director)
  • Board composition, KORYS BUSINESS SERVICES I NV (director)
  • Board composition, ORGANISATION-MANAGEMENT-CONSULTANCY and RELATIONS (director)
  • Board composition, KORYS MANAGEMENT (director)
  • Permanent representative, Dieter Struye
  • Permanent representative, Jérôme Gobbesso, mentioned 3 times in the deed
  • Permanent representative, Dries Colpaert
  • Permanent representative, Olivier Witmeur
  • Permanent representative, Thomas De Kempeneer
  • Capital, €67,500,000, 67,500 shares
  • Capital, €18,600, 186 shares, mentioned twice in the deed
  • Board composition, JGO (sole manager), mentioned twice in the deed
  • Accounting effect, 01-01-2019
  • NEWPHARMA GROUP holds all the shares
  • The deed holds 9 more points.

Open the deed in the Belgian Official Gazette

2018
Liquidity more than doubled current ratio 2.38 The current ratio rises from 1.06 to 2.38. Short-term debt falls from €91,776 to €992.
Annual accounts 2017 filed PDFfull format · on the deadline day
2017
Annual accounts 2016 filed PDFmicro format · 18 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 9 days late
2015
Annual accounts 2014 filed PDFabbreviated format · 54 days late
2014
Highest result from 2008 to 2018 net €467,922 ▲777% The operating result of €72,154 and the net result of €467,922 are both a record.
Equity above €500,000 equity €506,622 ▲1,209% After 2 profitable years in a row, equity reaches €506,622.
Annual accounts 2013 filed PDFabbreviated format · 29 days late
2013
Back to profit net €53,336 The net result is €53,336, after one loss-making year.
Annual accounts 2012 filed PDFabbreviated format · 26 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 26 days before the deadline
2011
Annual accounts 2010 filed PDFabbreviated format · 44 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 53 days before the deadline
2009
Back to profit net €343 The net result is €343, after one loss-making year.
Annual accounts 2008 filed PDFabbreviated format · 1 day before the deadline
2008
Incorporation PDF7 publications in the Belgian Official Gazette, the last on 27-06-2019

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

Company details

Purpose according to the articles of association

PurposeThe purpose describes the activities the company may carry out under its articles.
“La participation directe ou indirecte dans toutes sociétés; Le contrôle par la gestion ou la participation à la gestion par l'exercice d'un…”
8 activities
  1. La participation directe ou indirecte dans toutes sociétés
  2. Le contrôle par la gestion ou la participation à la gestion par l'exercice d'un mandat dans ces dernières
  3. S'intéresser à toutes activités financières ou boursières
  4. S'intéresser à toutes opérations commerciales et de marketing,internet compris
  5. Exercer toute activité de consultance
  6. S'intéresser à toute activité en tant qu'intermédiaire et consultant pour l'achat et la vente d'entreprises
  7. Exercer toutes activités mobilières et immobilières pour son compte propre
  8. Effectuer tout acte de commerce,dans le sens le plus large du terme,en ce qui concerne les programmes et le matériel informatique et les voitures neuves et d'occasions

Articles of association, deed of 18-04-2019 (in French)

Inactive

OPTIMIS is no longer in the KBO register.

Last annual accounts
financial year to 31 December 2018
Last registered office
Rue Du Charbonnage 10, 4020 Liege 2as published on 27 June 2019
Legal form
Private limited company (pre-2019)
First annual accounts
financial year 2008
Official KBO record

We would like to set cookies. That happens only with your consent. What we measure